Triclosan is a KCNQ3 potassium channel activator

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• KCNQ potassium channels (KCNQ2, KCNQ3, KCNQ5) are crucial for neuronal function, regulating action potential duration and preventing hyperexcitability.
• Dysfunction of KCNQ channels is linked to neurological disorders, including epilepsy, stroke, and traumatic brain injury.
• Pharmacological activation of KCNQ channels presents a promising therapeutic avenue for these hyperexcitability conditions.

Purpose of the Study:

• To investigate the effect of triclosan, a widely used bactericide, on KCNQ channel activity.
• To determine which KCNQ channel subtypes are modulated by triclosan.
• To elucidate the mechanism by which triclosan interacts with KCNQ channels.

Main Methods:

• Electrophysiological recordings to assess KCNQ channel activation.
• Site-directed mutagenesis to identify the triclosan binding site.
• Molecular docking simulations to predict the interaction between triclosan and KCNQ channels.

Main Results:

• Triclosan specifically activates KCNQ3 channels, with no observed effect on KCNQ2 channels.
• Triclosan modulates KCNQ3 channel gating by shifting the voltage dependence of activation, increasing conductance, and slowing channel closing.
• The observed effects are independent of phosphatidylinositol 4,5-bisphosphate (PIP2) and suggest a binding site within the voltage sensor domain.

Conclusions:

• Triclosan is identified as a novel activator of KCNQ3 potassium channels.
• The findings suggest triclosan's potential as a therapeutic agent for conditions associated with KCNQ channel dysfunction.
• Further research into triclosan's mechanism and efficacy in relevant disease models is warranted.